● SUCCESS STORY

CASE STUDY #1

Bile Duct Cancer

SUCCESS STORY

CASE STUDY #1

Bile Duct Cancer

Mr. Padmanathan

Stage 4 Bile Duct Cancer Diagnosis — July 2025

The difference between healing vs fear-driven decisions — and how one wrong choice dismantled months of remarkable progress.

CA 19-9 MARKER

852 → 77

91% reduction in 4 months

CHEMO DOSAGE

Reduced

Each time body improved on SHIELD

SHIELD PERIOD

Sept–Jan

4 months of measurable progress

CASE TIMELINE

Phase 1

Sept–Oct 2025

Foundation built

Phase 2

Oct–Dec 2025

Breakthrough

Phase 3

Jan–Feb 2026

Warning signs

Turning Point

Feb 2026

Fear enters

Phase 4

March 2026

System crash

DIAGNOSIS — JULY 2025

When Mr. Padmanathan was diagnosed, the disease was already advanced.

This was not just cancer — this was a system already under stress.

CA 19-9

~852

Extremely elevated — pancreatic/bile duct marker

HEMOGLOBIN

~9-10

Below normal — weak bone marrow signal

GGT & ALP

Elevated

Bile duct obstruction already present

PLATELETS

Unstable

Critical levels at presentation

Table 1: Mr Padmanathan’s C1 19-9 marker (marker for pancreatic cancer), and other markers.

Table 2 — CA 19-9 number from Sept 2025 – Jan 2026

PHASE 1 — BUILDING THE FOUNDATION | Sept–Oct 2025

A highly specific, personalized SHIELD plan was designed.

At this stage, the strategy was clear: correct the terrain, then let the body respond.

THE SHIELD PROTOCOL

— HemoHIM (immune + marrow support)

— Low-fat, low sugar, plant-based diet

— Liver support: milk thistle + detox strategy

— Gradual metabolic control

RESULTS IN 30 DAYS

+ Platelets recovered from critical levels

+ Inflammation stabilized

+ CA 19-9: 814 → 342 in just 30 days

His body started responding because the terrain was being corrected — and he's just 64 years old.

PHASE 2 — BREAKTHROUGH RESPONSE | Oct–Dec 2025

The strongest improvement phase.

Protocol strengthened each time he improved. Consistent HemoHIM, better diet adherence, TUDCA adjustments for bile flow.

CA 19-9 MARKER DROP (SEPT 2025 - DEC 2025)

852
Sept

→

314
Oct

→

77
Dec

↓91%
total reduction

Table 3 — Tumor marker table: trend + optimal range (CA 19-9 Sept 2025 – Jan 2026)

Liver & Inflammation Markers — ALP, GGT, ALT, AST, Bilirubin, CRP (Dec 2025 – Jan 2026)

Not chemotherapy. Not immunotherapy. It was improved bile flow, reduced inflammation, and better immune function — all driven by the personalized SHIELD protocol.

PHASE 3 — THE HIDDEN PROBLEM | Jan–Feb 2026

Even though things looked better, warning signs were still present.

These markers were telling a story that needed attention — not aggressive escalation.

GGT

~150

Still elevated — liver drainage incomplete

HEMOGLOBIN

Still low

Weak bone marrow — low red blood cells

ALP

Elevated

Liver still under stress

LIPASE

Rising

Early pancreatic stress signal

Table 2: Hemoglobin (Dec 2025 - 17 Jan 2026).

THE TURNING POINT — FEAR ENTERS | 17 Jan - 12 Feb 2026

This is where the story changes.

THE DOCTOR SAID:

'The chemo was supposed to keep the cancer under control' — from a doctor who only knows how to control cancer, but not to destroy it.

Susmitha, the primary caregiver, accepted this sudden decision out of fear — forgetting the confidence they had built from Sept 2025-Jan 2026, where chemo dosage was being reduced and SHIELD was working. Two things were being achieved simultaneously: killing the cancer AND strengthening the body. Both were undone by a single wrong decision.

FEAR-DRIVEN ACTION 1

Capecitabine started

FEAR-DRIVEN ACTION 2

Keytruda (immunotherapy) continued

Within 3 days: severe diarrhea, gut instability, treatment stopped temporarily.
'Your daddy's gut is already affected... this 2 stuff will worsen things.' — This was warned. And it happened.

THE CASCADE THAT FOLLOWED

  1. Keytruda → silent gut inflammation

  2. Capecitabine → acute gut damage

  3. Severe diarrhea → gut barrier breakdown

  4. Toxins flood liver → bile flow worsens

  5. → Pancreas stressed — system collapse begins

PHASE 4 — SYSTEM CRASH | March 2026

The labs confirmed everything.

Sudden abnormal results after Keytruda + Capecitabine — all from 9 March 2026.

GGT

150 → 400

+167% increase

ALP

156 → 264

+69% increase

LIPASE

74 → 150

+103% — pancreatic stress

CRP

43.5

Massive systemic inflammation

Table 4 — Summary abnormal results: 9 March 2026 after Keytruda & Capecitabine

Liver Function Test (LFT) with GGT — GGT is 6x higher than upper range = severe bile duct congestion

This was NOT tumor progression first.

This was a treatment-triggered system collapse.

WHAT WORKED VS WHAT DIDN'T

WHEN HE FOLLOWED THE PLAN — SEPT 2025-JAN 2026

HemoHIM consistently

Plant-based SHIELD diet

Liver support (TUDCA + milk thistle)

Gut-friendly foods

RESULT

CA 19-9 dropped massively • Platelets recovered • System stabilized

WHEN FEAR TOOK OVER — AFTER JAN 2026

Capecitabine introduced

Immunotherapy continued despite gut instability

RESULT

Severe diarrhea • Liver congestion worsened • Pancreas inflamed • CRP at 43.5

CRP result: 43.5 mg/L (reference 0–5) — massive systemic inflammation confirmed

CRITICAL INSIGHT — THIS IS THE DIFFERENCE THAT CHANGED EVERYTHING

DOCTOR'S MODEL

"Control the tumor"

Treat the symptom. Manage the cancer. Ignore the terrain.

SHIELD MODEL

"Fix the body → tumor responds"

Improve bile flow - Reduce inflammation - Strengthen the immune terrain.

Tumor marker was strongly linked to the biliary environment, not just tumor size. When bile flow improved and liver congestion reduced — CA 19-9 dropped, digestion improved, and stability returned.

THE BIGGEST LESSON FROM THIS CASE

The bile duct cancer did not suddenly worsen in him.

What worsened was their sudden mindset shift — from strong to weak — which caused gut integrity to fail, liver drainage to worsen, and pancreatic function to collapse.

You are NOT what you eat. You are what you ABSORB. Absorbing means it can be anything — not just food. But also drugs and treatments. Every input is processed through a compromised or strengthened system.

Mr. Padmanathan's journey shows that healing was possible when the body was supported, but declined when decisions were driven by fear rather than physiology. Now, we have re-made the Advanced SHIELD Protocol.

The difference between progress and collapse was not the cancer...

It was making fear-based decisions from people who are not living the dreams you wanna live.

— Nesa, KickkCancerOut

READY TO TAKE CONTROL?

Your body can heal — when given the right support.

Apply to work with Nesa one-on-one through the personalized SHIELD protocol.

This content is not medical advice and should always be used alongside guidance from your healthcare team.